“Pre and post licensing should not be two different lives, it’s one continuous life”: A Report From The DIA 2016 Session ”Europe and the US: Making Outcomes-Based Health Care Possible”

On 29 June 2016, key stakeholders and decision-makers in the field of real-world evidence met to take part in the DIA 2016 seminar “Europe and the US: Making Outcomes-Based Health Care Possible”. As Europe and the US continue to examine ways to develop therapies on the basis of their “real world” performances, the session aimed […]

By |August 29th, 2016|Uncategorized|0 Comments

Luk Maes Reports on DIA Hamburg’s “MAPPs: The IMI ADAPT SMART Project”: Views from Payers, Consumers and HTA Bodies

June 2016 – by Luk Maes

This April, thought leaders in the field of adaptive pathways met at the DIA EuroMeeting 2016 in Hamburg to discuss the progress made in MAPPs (“Medicines Adaptive Pathways to Patients”) —as well as the challenges still ahead. Co-chairing the panel “MAPPs: The IMI ADAPT SMART Project” was Luk Maes, Executive Director Scientific Policies […]

By |June 21st, 2016|Uncategorized|0 Comments

Susan Forda, BPharm, MSc, PhD, MRPhS

Vice President, International Regulatory Affairs Eli Lilly and Company

Sue trained as a pharmacist. After completing a PhD in neuropharmacology, she worked as a post-doctoral research fellow at St George’s Hospital Medical School, University of London. She later joined Beecham, subsequently SmithKline Beecham Pharmaceuticals, as a regulatory associate in their Worldwide Regulatory Affairs Department. Over a […]

By |March 1st, 2016|Uncategorized|0 Comments

About Marshall L. Summar

Chief, Division of Genetics and Metabolism
Vice-Chair, Special Projects
Magaret O’Malley Chair of Genetic Medicine, Chair of the Scientific and Medical Advisory Committee of the National Organization for Rare Disorders (NORD®)






Marshall L. Summar, MD, is Chief of the Division of Genetics and Metabolism at Children’s National Health System. He leads the largest clinical division of its kind in the […]

By |January 20th, 2016|Uncategorized|0 Comments

Interview with Marshall L. Summar: MAPPs in the Rare Disease Space

March 21st – by Alison Kilian






When it comes to rare diseases, it’s important to find the fastest path and look beyond traditional trial models to meet patients’ needs, says Marshall L. Summar, MD, co-chair of the rare disease advisory panel of Patient-Centered Outcomes Research Institute (PCORI) and the Scientific Advisory Committee of the National Organization […]

By |January 20th, 2016|Uncategorized|0 Comments

Event Report – MAPPs: Saving Time, Saving Lives

EFPIA General Meeting Highlights Enormous Gains Made by MAPPs and Carves a Path for the Future
17th June 2015 – by Duane Schulthess
While progress is often slow and laborious when trying to gain traction for new ideas in the ‘Brussels Bubble’, there was much to be optimistic about in the Medicine’s Adaptive Pathways to Patients (MAPPs) meeting […]

By |June 16th, 2015|News, Uncategorized|0 Comments